Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can inject Wegovy into your stomach (abdomen), thigh, or upper arm — all three sites are licensed for use, and your prescriber will confirm which suits you. The practical differences between stomach and thigh are real but small, and the right choice often comes down to your own body, your routine, and how confident you feel. As a prescription-only medicine, Wegovy requires clinical assessment and ongoing prescriber oversight; the injection-site question is one your clinical team is well placed to answer for your specific situation. Learn more about how Wegovy works and what treatment involves.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a question our prescribers hear most weeks: does it actually matter whether you use your stomach or your thigh? The short answer is no, not dramatically, but the longer answer is worth understanding, because the choices you make around site rotation do affect how reliably you absorb each dose over the months ahead.
Wegovy is injected subcutaneously, meaning just beneath the skin into the fatty tissue layer. The abdomen and thigh are both rich in that tissue, and the NHS medicines guidance for semaglutide confirms all three sites (abdomen, thigh, upper arm) as suitable. The upper arm is the only site where you'd normally need someone else to help; the abdomen and thigh are the two most people self-inject into, which is why this particular question comes up so often.
What the pharmacokinetic data shows is that peak absorption timing and overall bioavailability are comparable across the three sites for semaglutide at the doses used in Wegovy. Differences in body composition (specifically the thickness and consistency of subcutaneous fat at a given spot) tend to have more practical impact than the site label itself. A lean thigh with little subcutaneous tissue will deliver the dose less predictably than a well-padded abdomen, and vice versa. Your own body is the variable that matters most.
Whether you settle on the abdomen or the thigh, the principle of rotation applies inside that site as much as between sites. Injecting repeatedly into the exact same spot (the same centimetre of skin, week after week) causes a condition called lipohypertrophy: the subcutaneous fat hardens and thickens in response to repeated trauma. Semaglutide injected into lipohypertrophic tissue is absorbed erratically, which can blunt the medicine's effect even when you're doing everything else right.
The practical rule is to move at least two to three centimetres from the previous spot each week, working systematically around the available surface area. For the abdomen, that means the soft tissue a few centimetres away from the navel, avoiding the navel itself and the belt line. For the thigh, the outer front quadrant between hip and knee is the target zone, not the inner thigh, which has more blood vessels and nerve endings close to the surface.
If you also use insulin or another injectable, don't use the same anatomical region for both on the same day. The abdomen-specific guidance for Wegovy covers the spacing rules in more detail, and there's a parallel page on thigh injections for Wegovy if you want to go deeper on technique for that site.
Beyond the pharmacology, there are entirely practical reasons someone might favour the stomach or the thigh on any given week. Abdominal injections are often described as more accessible, easier to see, easier to pinch a fold of skin, and comfortable sitting or standing. People who are slimmer through the abdomen sometimes find the thigh gives them a larger available surface area and more subcutaneous tissue to work with.
Clothing is a factor too. If you're injecting at the office on a Tuesday afternoon, lifting a shirt at your desk is simpler than dropping trousers to reach your thigh. Some people switch between sites seasonally, using the abdomen in winter and rotating more freely in summer when clothing allows easier thigh access. None of this affects the medicine's safety or efficacy, it's just real life, and your prescriber won't judge the choice.
One thing worth knowing: if you're exploring whether one site produces noticeably better results for you personally, the evidence doesn't strongly support that expectation. A detailed look at the comparative question is covered on the page about whether Wegovy works better in the thigh or stomach, the short version is that technique and consistency matter more than geography. For side effects related to the injection itself, rather than the site question, the guide to Wegovy and stomach pain covers what's common, what passes, and what to flag to your prescriber.
The site is one variable; technique is the other. A correctly performed injection into a suboptimal site will deliver more reliably than a poorly performed injection into the ideal one. The key points apply equally to stomach and thigh: clean the skin with an alcohol swab and let it dry fully before injecting; pinch a fold of skin between finger and thumb to separate the subcutaneous layer from muscle; insert at a 90-degree angle for most people (or 45 degrees if you have very little subcutaneous tissue); inject slowly and hold the pen in place for a full ten seconds after the dose is delivered before removing it.
Storage is consistent across sites too, Wegovy pens are kept refrigerated between 2°C and 8°C, and the exact permitted room-temperature window before use is specified in the Patient Information Leaflet inside your pack. Always check that rather than going by memory. If you're looking at private treatment options, the weight-loss treatments page sets out how our clinical process works, and our prescribers can discuss injection technique during follow-up if anything isn't clear. You can also read about semaglutide more broadly to understand what the medicine is doing at each stage of treatment. Questions about accessing Wegovy privately are answered separately.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.